Phase I/II study of a combined gemcitabi
β
Tetsuro Tsukamoto; Junji Yonese; Yuhei Ohkubo; Iwao Fukui
π
Article
π
2006
π
John Wiley and Sons
π
English
β 112 KB
## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat